Columbus, Ohio
United States
19
2025-12-18
The entities that hold a legal rights for patent applications filed by inventor Ralph David A.:
David A. Ralph from Columbus, US has applied for patents for these inventions. The list has both pending applications and granted patents:
AMIDE LINKAGES OF SUGAR MOIETIES TO AMINE TERMINATED LEASHES ATTACHED TO CARBOHYDRATE POLYMERS
#2 | 2025-10-23COMPOSITIONS AND METHODS FOR ALTERING MACROPHAGE PHENOTYPE
#3 | 2024-09-05CD206 targeted drug delivery vehicles carrying novel bisphosphonate drug payloads via a degradable linker
#4 | 2024-04-25AMIDE LINKAGES OF SUGAR MOIETIES TO AMINE TERMINATED LEASHES ATTACHED TO CARBOHYDRATE POLYMERS
#5 | 2024-03-21SYNTHESIS OF UNIFORMLY DEFINED MOLECULAR WEIGHT MANNOSYLATED DEXTRANS AND DERIVATIVES THEREOF
#6 | 2024-03-07Altering net charge on mannosylated dextrans to maximize target tissue uptake and off target competitive blocking
#7 | 2024-01-25MANNOSYLATED AMINE DEXTRAN DRUG DELIVERY VEHICLES WITH DEGRADABLE DISULFIDE/CARBONATE LINKERS TARGETING PAYLOADS TO CD206 EXPRESSING CELLS
#8 | 2023-11-23CD206 targeted drug delivery vehicles carrying novel bisphosphonate drug payloads via a degradable linker
#9 | 2023-09-28Competitive Self-Blocking with Unlabeled Manocept Imaging Agents
#10 | 2023-08-10Altering net charge on mannosylated dextrans to maximize target tissue uptake and off target competitive blocking
#11 | 2023-07-13COMPOSITIONS AND METHODS FOR ALTERING MACROPHAGE PHENOTYPE
#12 | 2023-07-06METHODS FOR THE CONJUGATION OF ANTHRACYCLINES TO CARBOHYDRATE POLYMERIC CARRIERS
#13 | 2023-03-09COMPOSITIONS AND METHODS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
#14 | 2022-01-13Synthesis of uniformly defined molecular weight mannosylated dextrans and derivatives thereof
#15 | 2021-11-04Compounds and methods for diagnosis and treatment of viral infections
#16 | 2021-05-20COMPOSITIONS AND RELATED METHODS FOR BLOCKING OFF-TARGET LOCALIZATION OF MANNOSYLATED DEXTRANS AND OTHER CD206 LIGANDS
#17 | 2021-02-25COMPOSITIONS AND RELATED METHODS FOR THE ABLATION OF M2 MACROPHAGES AND MYELOID DERIVED SUPPRESSOR CELLS
#18 | 2020-10-01Compositions and methods for altering macrophage phenotype
#19 | 2020-07-30COMPOSITIONS AND METHODS FOR ASSESSING MACROPHAGE MEDIATED PATHOLOGY
2804726 ⎘